ASBMB Teams Up With ACS Division For San Francisco Joint Meeting

For the second time in three years, the American Society for Biochemistry and Molecular Biology (ASBMB) will hold its annual meeting together with the Division of Biological Chemistry of the American Chemical Society (ACS). The cooperative event will take place from Sunday, May 21 through Thursday, May 25 in San Francisco's Moscone Convention Center. More than 3,000 scientists are expected to attend the conference and exhibition, bringing together a broad span of chemists, biochemists, and biol

Written byHoward Goldner
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

For the second time in three years, the American Society for Biochemistry and Molecular Biology (ASBMB) will hold its annual meeting together with the Division of Biological Chemistry of the American Chemical Society (ACS). The cooperative event will take place from Sunday, May 21 through Thursday, May 25 in San Francisco's Moscone Convention Center.

More than 3,000 scientists are expected to attend the conference and exhibition, bringing together a broad span of chemists, biochemists, and biologists. Major themes of this 86th annual ASBMB meeting will include protein structure and function, intracellular trafficking, and DNA replication and expression. Also of interest will be the presentation of several awards to distinguished researchers.

"We anticipate another successful joint meeting this year," says Barbara Gordon, director of administration for Bethesda, Md.-based ASBMB, who notes that the society received many positive comments from attendees after the first combined meeting. "Not only do our members have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies